STRO

8.6001.38%
JC

Jane Chung

CEO & Director

Ms. Jane Chung, R.Ph., is Chief Executive Officer of Sutro Biopharma, Inc. from March 13, 2025 and served as its Chief Commercial Officer since August 09, 2021 until November 2023 and served as its Chief Operating Officer since November 2023 until March 13, 2025 and served as its President since 2023 until March 13, 2025, where she has been responsible for building and leading global commercialization. She joined Sutro Biopharma, Inc. on August 09, 2021. She served as a Director of Viracta Therapeutics, Inc. since August 2022 until October 31, 2024. She joined Viracta's Board with commercial leadership experience in the pharmaceutical and biotechnology industry, focused mostly on innovative oncology medicines and broadly across executive management, franchise leadership, marketing, sales, operations and market access functions. She served as the President of AstraZeneca Canada Inc. since 2019. She is a proven business and people leader with experience in the North American biopharmaceutical industry. With a strong focus on driving a culture of employee empowerment and engagement, she joined AZ Canada after playing a critical role in building and leading the company’s rapidly expanding Oncology franchise in the U.S. Most recently, she served as Vice President and Head of AstraZeneca’s U.S. Immuno-Oncology Franchise, where she was accountable for all aspects of marketing and sales of the company’s Immuno-Oncology medicines. From May 2015 to August 2021, she served in several leadership roles at AstraZeneca Pharmaceuticals, including as President and General Manager of AstraZeneca Canada, Vice President of Sales and Marketing of U.S. lmmuno-Oncology and Senior Commercial Business Director. Prior to this, she led the Oncology business in the U.S. West region as the Senior Commercial Business Director. Before joining AstraZeneca, she held diverse roles of increasing responsibility with Onyx Pharmaceuticals, Genentech, Novartis and Pharmacia. Before joining AstraZeneca in 2015, she was Oncology Region Sales Director and Hematology Director at Onyx Pharmaceuticals in San Francisco. From 2003 to 2013, she held diverse leadership roles at Genentech in Commercial Operations, Marketing and Sales. Prior to that, from May 2013 to May 2015, she served as a Regional Sales Director and Director of Sales Productivity and Effectiveness for Onyx Pharmaceuticals Inc. From October 2003 to May 2013, she served in various commercial roles for Genentech, Inc. including as Commercial Operations Manager, Division Manager and Senior Marketing Manager. Inc. including as Commercial Operations Manager, Division Manager and Senior Marketing Manager. She holds a B.A. degree from Columbia University, New York and received a B.S. in Pharmacy from St. John's University.

Positions